Small-cap pharma stock hits 52-week high after fundraising move. Details here (opens original article in a new tab)

Sudarshan Pharma shares hit a 52-week high following a fundraising announcement, with significant long-term returns.

• Sudarshan Pharma share price hit a 52-week high after announcing a fundraising proposal.
• The company plans to raise funds through various instruments including equity shares and debt securities.
• Shares have delivered significant returns, with 438% gains over the past three years.